T1	ANAT 58 66	sinovial
#1	AnnotatorNotes T1	C0039099; Synovial Membrane; Body Part, Organ, or Organ Component
T2	PROC 476 500	consentimiento informado
#2	AnnotatorNotes T2	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T3	PROC 46 66	Ultrasonido sinovial
#3	AnnotatorNotes T3	C0845889; Musculoskeletal ultrasound; Diagnostic Procedure
T4	PROC 98 209	estudio internacional, multicéntrico, aleatorizado, abierto de 3 brazos, con control activo de grupos paralelos
T5	CHEM 255 266	metotrexato
#4	AnnotatorNotes T5	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T6	CHEM 279 294	inhibidor TNF-α
T7	DISO 312 331	artritis reumatoide
#5	AnnotatorNotes T7	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T8	ANAT 354 364	sinoviales
#6	AnnotatorNotes T8	C0039099; Synovial Membrane; Body Part, Organ, or Organ Component
T9	DISO 402 421	Artritis reumatoide
#7	AnnotatorNotes T9	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T10	PROC 572 586	procedimientos
#8	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T11	PROC 625 638	cuestionarios
#9	AnnotatorNotes T11	C2960239; Assessment using health assessment questionnaire; Health Care Activity | C1882515; Questionnaire Administration; Health Care Activity
T12	PROC 669 678	protocolo
#10	AnnotatorNotes T12	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T13	DISO 795 797	AR
#11	AnnotatorNotes T13	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T14	PROC 798 811	diagnosticado
#12	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	DISO 874 876	AR
#13	AnnotatorNotes T15	C0003873; Rheumatoid Arthritis; Disease or Syndrome
T16	DISO 897 907	enfermedad
#14	AnnotatorNotes T16	C0012634; Disease; Disease or Syndrome
T17	DISO 968 978	enfermedad
#15	AnnotatorNotes T17	C0012634; Disease; Disease or Syndrome
T18	ANAT 987 1001	articulaciones
#16	AnnotatorNotes T18	C0022417; Joints; Body Space or Junction | C1269611; Entire joint; Body Space or Junction
T19	CHEM 1045 1048	MTX
#17	AnnotatorNotes T19	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T20	PROC 1244 1251	terapia
#18	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	DISO 1417 1428	infecciones
#19	AnnotatorNotes T21	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T22	DISO 1450 1470	tuberculosis latente
#20	AnnotatorNotes T22	C1609538; Latent Tuberculosis; Disease or Syndrome
T23	DISO 1504 1510	cáncer
#21	AnnotatorNotes T23	C0006826; Malignant Neoplasms; Neoplastic Process
T24	PROC 1540 1550	vacunación
#22	AnnotatorNotes T24	C0042196; Vaccination; Therapeutic or Preventive Procedure
T25	PROC 1646 1657	tratamiento
#23	AnnotatorNotes T25	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T26	CHEM 1679 1689	medicación
#24	AnnotatorNotes T26	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T27	PROC 1693 1700	rescate
#25	AnnotatorNotes T27	C0085405; Salvage Therapy; Therapeutic or Preventive Procedure
T28	CHEM 1739 1751	medicamentos
#26	AnnotatorNotes T28	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T29	PROC 1752 1761	recetados
#27	AnnotatorNotes T29	C0033080; Prescription procedure; Health Care Activity
T30	PROC 1784 1797	examen físico
#28	AnnotatorNotes T30	C0031809; Physical Examination; Health Care Activity
T31	CHEM 1799 1809	medicación
#29	AnnotatorNotes T31	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T32	DISO 1830 1867	enfermedades sistémicas concomitantes
T33	DISO 1872 1886	Complicaciones
#30	AnnotatorNotes T33	C0009566; Complication; Pathologic Function
T34	DISO 1979 1996	Hipersensibilidad
#31	AnnotatorNotes T34	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T35	DISO 1999 2006	alergia
#32	AnnotatorNotes T35	C1527304; Allergic Reaction; Pathologic Function
T36	CHEM 2069 2080	medicamento
#33	AnnotatorNotes T36	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T37	CHEM 2144 2155	medicamento
#34	AnnotatorNotes T37	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T38	PROC 1920 1938	asignación al azar
T39	PROC 2185 2196	tratamiento
#35	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T40	PROC 2244 2269	evaluación de la eficacia
#36	AnnotatorNotes T40	C1707887; Efficacy Study; Research Activity
T41	PROC 2274 2285	tratamiento
#37	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	PROC 2315 2341	tratamiento anticoagulante
#38	AnnotatorNotes T42	C0150457; Anticoagulant therapy; Therapeutic or Preventive Procedure
T43	CHEM 222 233	baricitinib
#39	AnnotatorNotes T43	C4044947; baricitinib; Organic Chemical · Pharmacologic Substance
T44	PROC 753 777	consentimiento informado
#40	AnnotatorNotes T44	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T45	CHEM 1256 1315	medicamentos antirreumáticos modificadores de la enfermedad
#41	AnnotatorNotes T45	C0242708; Antirheumatic Drugs, Disease-Modifying; Pharmacologic Substance
T46	CHEM 1337 1342	DMARD
#42	AnnotatorNotes T46	C0242708; Antirheumatic Drugs, Disease-Modifying; Pharmacologic Substance
T47	CHEM 2012 2022	medicación
#43	AnnotatorNotes T47	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T48	CHEM 2211 2222	medicamento
#44	AnnotatorNotes T48	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T49	CHEM 2327 2341	anticoagulante
#45	AnnotatorNotes T49	C0003280; Anticoagulants; Pharmacologic Substance
T50	Date 13 17	2018
T51	LIVB 298 307	pacientes
#46	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 451 459	Paciente
#47	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	LIVB 683 688	Mujer
#48	AnnotatorNotes T53	C0043210; Woman; Population Group
T54	LIVB 691 697	hombre
#49	AnnotatorNotes T54	C0025266; Male population group; Population Group
T55	Age 699 714	de 18 a 75 años
T56	LIVB 782 790	Paciente
#50	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	Date 864 868	2010
T58	Duration 1084 1100	al menos 3 meses
T59	Dose 1145 1173	una dosis estable de ≤ 25 mg
T61	Frequency 1174 1182	/ semana
T62	LIVB 1187 1196	Pacientes
#51	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	LIVB 1581 1589	Paciente
#52	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	LIVB 1609 1621	investigador
#53	AnnotatorNotes T64	C0035173; Research Personnel; Professional or Occupational Group
T65	LIVB 1962 1974	investigador
#54	AnnotatorNotes T65	C0035173; Research Personnel; Professional or Occupational Group
T66	LIVB 2039 2048	Pacientes
#55	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T68	LIVB 2172 2181	Pacientes
#56	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T70	LIVB 2302 2311	Pacientes
#57	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	LIVB 2346 2365	Mujeres embarazadas
#58	AnnotatorNotes T71	C0033011; Pregnant Women; Population Group
T72	LIVB 2368 2377	lactantes
#59	AnnotatorNotes T72	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T73	DISO 1305 1315	enfermedad
#60	AnnotatorNotes T73	C0012634; Disease; Disease or Syndrome
T74	Neg_cue 1405 1416	Ausencia de
T75	Neg_cue 1438 1449	ausencia de
T67	PHYS 2354 2365	embarazadas
#61	AnnotatorNotes T67	C0032961; Pregnancy; Organism Function
T60	PHYS 533 541	entender
#62	AnnotatorNotes T60	C0162340; Comprehension; Mental Process
T69	PHYS 505 527	Mentalmente competente
#63	AnnotatorNotes T69	C0562342; Empowered; Mental Process
T76	Quantifier_or_Qualifier 1120 1133	de referencia
T77	PROC 1113 1119	visita
#65	AnnotatorNotes T77	C1512346; Patient Visit; Health Care Activity
A1	Assertion T21 Negated
A2	Assertion T22 Negated
#66	AnnotatorNotes T6	C3537192; Tumor Necrosis Factor Inhibitors; Pharmacologic Substance 
#67	AnnotatorNotes T32	C0243087; concomitant disease; Pathologic Function + C0442893; Systemic disease; Disease or Syndrome
#68	AnnotatorNotes T38	C0034656; Randomization; Research Activity
T78	Spec_cue 2099 2124	podría ser susceptible de
T79	Observation 2125 2155	interactuar con el medicamento
A3	Assertion T79 Speculated
#64	AnnotatorNotes T79	C3840750; Potential adverse drug interaction; Finding
R1	Negation Arg1:T74 Arg2:T21	
T80	Quantifier_or_Qualifier 1429 1436	activas
A4	Assertion T80 Negated
#69	AnnotatorNotes T80	C0679217; Active State; Idea or Concept
R2	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T80	
R3	Negation Arg1:T75 Arg2:T22	
A5	Status T35 History_of
A6	Status T34 History_of
R4	Speculation Arg1:T78 Arg2:T79	
T81	Spec_cue 2227 2232	pueda
T82	CONC 2233 2240	afectar
A7	Assertion T82 Speculated
#70	AnnotatorNotes T82	C0521102; Interferes with; Functional Concept
R5	Speculation Arg1:T81 Arg2:T82	
R6	Location_of Arg1:T1 Arg2:T3	
R7	Combined_with Arg1:T43 Arg2:T5	
T83	Quantifier_or_Qualifier 234 238	solo
R8	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T83	
R9	Experiences Arg1:T51 Arg2:T43	
R10	Experiences Arg1:T51 Arg2:T6	
R12	Experiences Arg1:T51 Arg2:T7	
T84	Observation 368 377	respuesta
#71	AnnotatorNotes T84	C1319171; Medication response; Finding
R13	Experiences Arg1:T51 Arg2:T84	
R14	Overlap Arg1:T43 Arg2:T84	
R15	Overlap Arg1:T5 Arg2:T84	
R16	Overlap Arg1:T6 Arg2:T84	
T85	Observation 460 465	capaz
#72	AnnotatorNotes T85		C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R17	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T85	
R18	Overlap Arg1:T85 Arg2:T2	
T86	Observation 544 553	dispuesto
#73	AnnotatorNotes T86	C0600109; Willing; Finding
R19	Overlap Arg1:T86 Arg2:T10	
R20	Overlap Arg1:T60 Arg2:T10	
R21	Overlap Arg1:T69 Arg2:T10	
R22	Overlap Arg1:T69 Arg2:T11	
R23	Overlap Arg1:T60 Arg2:T11	
R24	Overlap Arg1:T86 Arg2:T11	
R25	Has_Age Arg1:T53 Arg2:T55	
R26	Has_Age Arg1:T54 Arg2:T55	
R27	Overlap Arg1:T44 Arg2:T55	
R28	Experiences Arg1:T56 Arg2:T13	
R29	Experiences Arg1:T56 Arg2:T15	
T87	CONC 822 868	criterios de clasificación ACR / EULAR de 2010
R30	Used_for Arg1:T87 Arg2:T14	
T88	Quantifier_or_Qualifier 911 927	moderada a grave
#74	AnnotatorNotes T88	C1299393; Moderate to severe; Qualitative Concept
R31	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T88	
T89	CONC 1003 1008	DAS28
#75	AnnotatorNotes T89	C2732493; Disease activity score 28 joint in rheumatoid arthritis; Intellectual Product
T90	Result_or_Value 1010 1015	≥ 3.2
R32	Has_Result_or_Value Arg1:T89 Arg2:T90	
T91	CONC 938 1001	puntuación de actividad de la enfermedad para 28 articulaciones
#76	AnnotatorNotes T91	C2732493; Disease activity score 28 joint in rheumatoid arthritis; Intellectual Product
R33	Location_of Arg1:T18 Arg2:T17	
R34	Has_Result_or_Value Arg1:T91 Arg2:T90	
R35	Overlap Arg1:T16 Arg2:T91	
R36	Overlap Arg1:T16 Arg2:T89	
R37	Overlap Arg1:T19 Arg2:T58	
R38	Before Arg1:T19 Arg2:T77	
R39	Has_Quantifier_or_Qualifier Arg1:T77 Arg2:T76	
R40	Has_Dose_or_Strength Arg1:T19 Arg2:T59	
R41	Has_Frequency Arg1:T19 Arg2:T61	
T92	Observation 1021 1041	Respuesta inadecuada
#77	AnnotatorNotes T92	C0858218; Inappropriate drug response; Finding
R42	Overlap Arg1:T92 Arg2:T19	
R43	Experiences Arg1:T62 Arg2:T20	
R44	Used_for Arg1:T45 Arg2:T20	
T93	Quantifier_or_Qualifier 1316 1325	sintética
R45	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T93	
R46	Used_for Arg1:T46 Arg2:T20	
T94	Quantifier_or_Qualifier 1326 1335	biológica
#78	AnnotatorNotes T94	C0205460; biological; Qualitative Concept
R47	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T94	
R48	Experiences Arg1:T62 Arg2:T21	
R49	Experiences Arg1:T62 Arg2:T22	
R50	Experiences Arg1:T62 Arg2:T23	
R51	Experiences Arg1:T62 Arg2:T24	
T95	Observation 1627 1657	inadecuado para el tratamiento
#79	AnnotatorNotes T95	C0749654; TREATMENT NOT ELIGIBLE; Finding
R52	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T95	
R54	Experiences Arg1:T63 Arg2:T25	
R55	Used_for Arg1:T26 Arg2:T27	
R56	Experiences Arg1:T63 Arg2:T26	
R57	Experiences Arg1:T63 Arg2:T28	
T96	CONC 1766 1782	historial médico
#80	AnnotatorNotes T96	C5204342; Clinical History; Intellectual Product
R58	Experiences Arg1:T63 Arg2:T30	
R59	Experiences Arg1:T63 Arg2:T31	
T97	Quantifier_or_Qualifier 1810 1822	concomitante
#81	AnnotatorNotes T97	C0521115; Simultaneous; Temporal Concept
R60	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T97	
R61	Experiences Arg1:T63 Arg2:T32	
R62	Before Arg1:T30 Arg2:T95	
R63	Before Arg1:T96 Arg2:T95	
R64	Before Arg1:T28 Arg2:T95	
R65	Before Arg1:T29 Arg2:T95	
R66	Before Arg1:T31 Arg2:T95	
R67	Before Arg1:T32 Arg2:T95	
R68	Before Arg1:T33 Arg2:T38	
R69	Causes Arg1:T47 Arg2:T34	
R70	Causes Arg1:T47 Arg2:T35	
R71	Experiences Arg1:T66 Arg2:T36	
T98	Quantifier_or_Qualifier 2081 2093	concomitante
#82	AnnotatorNotes T98	C0521115; Simultaneous; Temporal Concept
R72	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T98	
R73	Before Arg1:T36 Arg2:T79	
R74	Causes Arg1:T37 Arg2:T79	
R75	Experiences Arg1:T66 Arg2:T79	
R76	Experiences Arg1:T66 Arg2:T37	
R77	Experiences Arg1:T68 Arg2:T39	
R78	Used_for Arg1:T48 Arg2:T39	
R80	Experiences Arg1:T68 Arg2:T41	
R81	Used_for Arg1:T49 Arg2:T42	
R82	Experiences Arg1:T70 Arg2:T42	
R83	Experiences Arg1:T71 Arg2:T67	
R84	Location_of Arg1:T18 Arg2:T16	
#83	AnnotatorNotes T83	C0205171; Singular; Quantitative Concept
R11	Negation Arg1:T74 Arg2:T80	
R85	Experiences Arg1:T62 Arg2:T73	
#84	AnnotatorNotes T76	C1442488; Baseline; Quantitative Concept
A8	Experiencer T51 Patient
A9	Experiencer T52 Patient
A10	Status T10 Future
A11	Experiencer T54 Patient
A12	Experiencer T53 Patient
A13	Experiencer T56 Patient
A14	Experiencer T62 Patient
A15	Experiencer T63 Patient
A16	Experiencer T64 Other
A17	Experiencer T65 Other
A18	Experiencer T66 Patient
A19	Experiencer T68 Patient
A20	Experiencer T70 Patient
A21	Experiencer T72 Patient
A22	Experiencer T71 Patient
